Test of anti-human CD30endo monoclonal antibodies. (A) GST fusion proteins were produced and used to coat microtiter plates (1 µg/mL protein in 50 mM carbonate buffer, pH 9.2). Culture supernatants of hybridomas were applied as indicated (B). Binding was detected by horseradish peroxidase-coupled anti-mouse IgG. (C) Western blot of L540 (CD30-positive) and HD-MyZ (CD30-negative; control) cell lysates with culture supernatants of the anti-human CD30endo hybridomas Ki-10 and Ki-12. The Ki-2 mAb detects the CD30 ectodomain and serves as positive control.
MATERIALS AND METHODS

Immunization and production of anti-endoCD30 monoclonal antibodies
BALB/c mice (3-4 months old, Charles River, Cologne, Germany) received primary i.p. immunizations with 100 μg of the purified recombinant fusion protein containing glutathion-S-transferase and the endoplasmic domain of human CD30 (GST-humCD30 AA406-595 ), which was dissolved in 60 µL PBS and emulsified with 40 µL of Gerbu adjuvant MM (Gerbu Biotech., Heidelberg, Germany). The mice were boosted i.p. on day 7, 14 and 21 with 50 μg of CD30-GST fusion protein emulsified with 20% of the adjuvant. The last two doses (50 μg of CD30-GST) were performed on day 28 and 29 without adjuvant, while fusion was done on day 30.
Spleen cells from immunized animals were collected and fused with Ag8.653 myeloma cells using polyethylene glycol 1500 (Roche Diagnostics, Mannheim, Germany). The fused cells were cultured in selection medium (HAT, Sigma-Aldrich, Deisenhofen, Germany) for 10 days. The antibodies were selected for reactivity with parts of the human CD30 endodomain, GST-humCD30 AA406-595 , GSThumCD30 AA464-595 , GST-humCD30 AA500-595 and with GST alone. 
